Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
TULP4 |
tubby like protein 4 |
6q25-q26 |
1(1/0/0)
|
IEA
|
ADRA1B |
adrenoceptor alpha 1B |
5q33.3 |
1(1/0/0)
|
TAS[10820200]
|
GNAZ |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
22q11.1-q11.2 |
1(1/0/0)
|
TAS[2456569]
|
TRAIP |
TRAF interacting protein |
3p21.31 |
1(0/0/1)
|
IEA
|
GNB1L |
guanine nucleotide binding protein (G protein), beta polypeptide 1-like |
22q11.2 |
1(1/0/0)
|
NAS[11072084]
|
PPP1R1B |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
17q12 |
1(0/1/0)
|
IBA
|
ADRA1A |
adrenoceptor alpha 1A |
8p21.2 |
2(0/2/0)
|
TAS[10671514]
|
PLA2G1B |
phospholipase A2, group IB (pancreas) |
12q24.31 |
4(1/3/0)
|
ISS[15528384]
|
CDC42BPB |
CDC42 binding protein kinase beta (DMPK-like) |
14q32.32 |
1(0/1/0)
|
IEA
|
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
7q35-q36 |
1(1/0/0)
|
IMP[15877279]
|
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
3p21.31 |
1(0/1/0)
|
IEA
|
DRD2 |
dopamine receptor D2 |
11q22-q23 |
28(8/20/0)
|
IDA[1331329]
|
RGS7 |
regulator of G-protein signaling 7 |
1q43 |
1(0/1/0)
|
IEA
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
TAS
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
7p22 |
1(1/0/0)
|
TAS[9572733]
|
NRG1 |
neuregulin 1 |
8p12 |
15(10/5/0)
|
IBA
|
ADCY2 |
adenylate cyclase 2 (brain) |
5p15.3 |
2(1/1/0)
|
IEA
|
DGKB |
diacylglycerol kinase, beta 90kDa |
7p21.2 |
1(1/0/0)
|
IEA
|
CIT |
citron rho-interacting serine/threonine kinase |
12q24.23 |
2(1/1/0)
|
IEA
|
NRG3 |
neuregulin 3 |
10q23.1 |
2(0/2/0)
|
IBA
|
DGKH |
diacylglycerol kinase, eta |
13q13.3 |
6(3/3/0)
|
IEA
|
ARHGEF5 |
Rho guanine nucleotide exchange factor (GEF) 5 |
7q35 |
1(1/0/0)
|
IEA
|
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
6q21 |
1(1/0/0)
|
TAS[1361685]
|
NEK4 |
NIMA-related kinase 4 |
3p21.1 |
1(1/0/0)
|
IBA
|
PRKCE |
protein kinase C, epsilon |
2p21 |
1(0/1/0)
|
IEA
|
STK39 |
serine threonine kinase 39 |
2q24.3 |
2(0/2/0)
|
IDA[24393035]
|
PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
17q24.2 |
1(1/0/0)
|
TAS[1889088]
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
14q32.33 |
3(3/0/0)
|
IDA[14749367]
|
GRIP1 |
glutamate receptor interacting protein 1 |
12q13.13 |
1(1/0/0)
|
NAS[10197531]
|
YWHAE |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon |
17p13.3 |
1(0/1/0)
|
TAS[7644510]
|
ITK |
IL2-inducible T-cell kinase |
5q31-q32 |
1(1/0/0)
|
IEA
|
PLCL2 |
phospholipase C-like 2 |
3p24.3 |
1(0/1/0)
|
IEA
|
ADCY8 |
adenylate cyclase 8 (brain) |
8q24 |
4(2/1/1)
|
IEA
|
JAK1 |
Janus kinase 1 |
1p32.3-p31.3 |
1(0/1/0)
|
IEA
|
ADCY9 |
adenylate cyclase 9 |
16p13.3 |
2(1/1/0)
|
IEA
|
NRGN |
neurogranin (protein kinase C substrate, RC3) |
11q24 |
2(1/1/0)
|
IBA
|
SLK |
STE20-like kinase |
10q25.1 |
1(0/0/1)
|
IBA
|
GSK3B |
glycogen synthase kinase 3 beta |
3q13.3 |
8(0/8/0)
|
IDA[14749367]
|